Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Technetium-99m hexakis 2-methoxyisobutyl isonitrile: Human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:5820290
The biodistribution, dosimetry, and safety of a new myocardial imaging agent, /sup 99m/Tc-hexakis-2-methoxyisobutyl isonitrile (HEXAMIBI), was evaluated in 17 normal volunteers at rest and exercise (Phase I studies). Technetium-99m HEXAMIBI clears rapidly from the blood with good myocardial uptake and favorable myocardial-to-background ratios for myocardial imaging. Dosimetry allows for administration of up to 30 mCi (1, 110 Bq) of (/sup 99m/Tc)HEXAMIBI. The myocardial images were of good quality and appeared less granular with sharper myocardial walls compared to /sup 201/T1 images. The clinical efficacy of (/sup 99m/Tc)HEXAMIBI planar stress and rest imaging was evaluated in a multicenter Phase II clinical trial involving 38 patients. Of 36 patients with significant coronary artery disease, 35 patients (97%) had abnormal /sup 201/T1 stress images, and 32 (89%) had abnormal (/sup 99m/Tc)HEXAMIBI stress images (P = N.S.). Technetium-99m HEXAMIBI images correlated in 31/35 patients (86%) who had either scar or ischemia on /sup 201/T1 images. By segmental myocardial analysis, exact concordance was obtained in 463/570 myocardial segments (81%). This multicenter Phase I and II study indicates that planar (/sup 99m/Tc)HEXAMIBI stress imaging is safe and compares well with /sup 201/T1 stress imaging for detection of coronary artery disease.
Research Organization:
Yale Univ. School of Medicine, New Haven, CT (USA)
OSTI ID:
5820290
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 30:3; ISSN JNMEA
Country of Publication:
United States
Language:
English